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INCIDENCE OF MYOCARDIAL 
INFARCTION IN CORONARY ARTERIES 
WITH PREVIOUSLY NON SIGNIFICANT 
STENOSIS (<50%) IDENTIFIED ON ANGIOGRAPHY
ABSTRACT
The objective o f this study was to determine the frequency o f myocardial infarctions in 
coronary arteries with previously non-significant (<50%) stenosis identified on coronary 
angiography. The angiograms o f ten subjects who had undergone cardiac catheterization 
prior to their acute myocardial infarction were evaluated. Six o f the ten subjects (60%) 
were found to have an acute myocardial infarction in areas supplied by vessels with 
<50% stenosis identified on previous angiography. Three of these six subjects had 
underwent percutaneous transluminal coronary angioplasty (PTCA) after angiography 
and one subject undergone coronary artery bypass grafting (C ABG) prior to the initial 
angiogram. Four o f the ten subjects (40%) included those who had >50% stenosis 
identified on prior angiography in the infarct related artery. Although this study involved 
a small sample that did not yield statistically significant results, the data did point to the 
fact that an acute myocardial infarction can occur in vessels with non-significant (<50%) 
stenosis.
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CHAPTER I 
INTRODUCTION
Background to Problem 
“No disease in the United States is responsible for more deaths, has stimulated 
more research, and has engendered more controversy about how best to control it than 
atherosclerosis (AS)."' Additionally, acute myocardial infarction (AMI), one 
complication o f AS, is the single most common cause of death in industrialized nations 
each year, and in the United States alone, results in roughly 500,000 fatalities of the 
estimated 1.5 million per year.' AS is characterized by the formation o f fibrofatty 
plaques, or atheromas, which develop in the intimai layer of blood vessel walls and can 
protrude into the vessel lumen and result in a weakening of the underlying medial layer 
o f the vessel. Although AS can affect any artery in the body, it most commonly occurs in 
the aorta, coronary and cerebral vessels. Symptoms resulting from AS in the coronary 
arteries can range from a mild, asymptomatic stage to a more severe, symptomatic stage 
which includes dyspnea at rest or on exertion, chest pain, and diaphoresis. Complications 
resulting from severe cases of AS in the coronary vasculature include ischemic heart 
disease with congestive heart failure, angina pectoris, AMI and sudden death.'
Researchers have proposed several hypotheses regarding the pathogenesis of AS. 
Currently, the Response-to-Injury Hypothesis is receiving the most attention in the 
literature.'^ This hypothesis proposes that chronic or repeated injury to the endothelium 
o f blood vessels results in some form o f nondenuding, subtle injury which initiates
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atherosclerotic changes. Once these injuring mechanisms are put into action, AS 
begins to follow a well documented pattern o f development.^
Progression o f AS is classified in advancing stages I through VI. Stage V and VI 
lesions are referred to as advanced or complicated and are responsible for producing 
acute symptoms when they fissure or break open and their thrombogenic substances are 
exposed.^ ® A detailed description o f development and progression o f  AS in the coronary 
arteries, otherwise known as coronary artery disease (CAD) is provided in the Literature 
Review.
Currently, coronary angiography is the “gold” standard clinical tool for evaluating 
patients with CAD  ^ The objective o f coronary angiography is to examine the entire 
epicardial coronary tree, recording details o f coronary anatomy that include the individual 
pattern o f arterial distribution, anatomic or functional pathology, and the presence of 
inter- and intracoronary collaterals.*"'“ Coronary angiography is used not only in the 
diagnosis o f coronary artery disease, but also to assess the appropriateness and feasibility 
of various forms o f  therapy aimed directly at the coronary arteries. Additionally, 
information provided by coronary angiography is useful for assessing the results of 
therapy and in helping to formulate prognoses in patients with CAD '
Conventionally, the degree of coronary artery obstruction is estimated as the 
percent reduction o f the luminal diameter, determined by comparing the diameter at the 
site of maximal reduction to that in adjacent areas that appear either normal or only 
minimally diseased. A fundamental assumption in the evaluation o f “percent stenosis” is 
that the angiographically “normal” segment o f the coronary artery adjacent to the lesion 
is free o f atherosclerotic disease.^
A majority o f  the current literature evaluating CAD distinguishes between 
severity o f lesions by referring to them as “non-significant” or “significant” stenosis. 
Non-significant stenoses are those which occlude <50% o f the arterial lumen and 
significant stenoses occlude >50% of the arterial lumen.*’ '* Although there is significant 
interobserver variability using this conventional interpretation of coronary artery 
obstructions, it remains clinically useful and is the most widely interpretation applied."
Studies have shown that significant stenosis o f >70% and total obstruction of a 
vessel are responsible for stable and unstable angina, as well as AMI.'"'* Generally, 
when symptomatic obstruction is >70%, procedures such as coronary artery bypass 
grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) are 
performed to reestablish blood flow to the myocardium. These have been successful in 
the treatment o f stenosis and total obstruction o f  the coronary arteries.
The procedures mentioned above, however, do not provide a means o f  treatment 
for those vessels which are <50% stenosed, or even <70% as a general rule. Stenoses 
which commonly are referred to as “insignificant” are usually asymptomatic or mildly 
symptomatic until they produce an AMI. S t u d i e s ' c o n d u c t e d  previously indicate that 
stenoses <50% are just as prone, if not more likely, to rupture and thrombose causing an 
AMI than those stenoses >50%.
Problem Statement
A significant number o f AMI’s occur fi"om lesions which cause <50% occlusion; 
however, mechanical interventions focus on treatment o f symptomatic lesions which 
cause >70% occlusion.
Purpose
In an effort to support previous studies, the purpose of this study is to
determine if individuals with a history o f an AMI have evidence of a non-significant 
stenosis on a pre-AMI angiogram in the coronary vasculature supplying that myocardial 
territory.
Significance o f the Problem
The effectiveness o f CABG and PTCA procedures have been demonstrated. 
However, Little, et al.^ noted in their study that 57% of AMI’s occurred in patients who 
previously had PTCA, but the AMI had resulted from an untreated stenosis. Thirty-three 
percent of AMI’s occurred after CABG, but fi"om a stenosis in a non-bypassed artery. In 
addition, two studies conducted by Kerensky, et al.^^^ noted similar results after PTCA.
In one study, 57% o f AMI’s occurring more than two weeks after successful PTCA were 
due to an occlusion at a location other than the angioplasty site. In the second study, 64% 
of AMI’s after PTCA occurred at a location other than the angioplasty site.
This raises two issues. First, angiographical studies may not be able to predict 
which stenosed artery will ultimately cause an AMI in many cases. Second, should 
treatment be developed and directed toward insignificant lesions, in addition to the 
significant lesions which currently are being targeted for treatment? In fact, wouldn’t 
therapy directed at the whole coronary tree be ideal?
Hvpothesis
Myocardial infarction fi’equently occurs in coronary arteries with previously non­
significant stenosis (<50%) identified on angiography.
CHAPTER 2 
LITERATURE REVIEW
Introduction
Billions o f  dollars are spent each year on the prevention, treatment, complications 
and research of atherosclerosis (AS). AS and its sequelae cause significant morbidity and 
mortality in the United States and other westernized nations. Although we have 
discovered a great deal about our nations number one killer in the last 20 years, we still 
struggle to find effective prevention and treatment.
Atherosclerosis affects the intimai layer of arteries, particularly medium and 
larger-sized arteries. It is a progressive disease that begins in childhood and usually does 
not produce symptoms until middle to late adulthood. Although AS can affect the entire 
vascular system, it typically manifests itself as coronary artery disease (CAD), cerebral 
vascular disease, aortic aneurysm and/or peripheral vascular disease, all o f  which may 
elicit dangerous symptoms or sudden death if left untreated. Since the focus o f this study 
is on CAD and its sequelae, the remainder o f this literature review will focus on 
atherosclerotic development in the coronary vasculature.
It is known that advanced areas of AS in the coronary arteries can cause cardiac 
tissue ischemia and death. The purpose o f  this study is to determine if  individuals 
with a history o f AMI have evidence of a non-significant stenosis on a pre-AMI 
angiogram in the coronary vasculature supplying that myocardial territory. The 
hypothesis of this study proposes that myocardial infarction frequently occurs in arteries 
with previously non-significant stenosis (<50%) identified on coronary angiography.
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In order to study the relationship between AS and AMI, several topics must be 
considered. This literature review will include a brief review of normal coronary 
anatomy, descriptions o f the development and progression of AS, an overview of 
diagnostic tests available to evaluate CAD and the current recommended medical and 
surgical treatments for CAD. Additionally, current research examining arterial stenosis 
and its relationship to AMI will be presented.
Arterial Anatomv
An artery is made up of three major layers: the adventitia, media and intima. The 
adventitia is the outermost layer and is made up o f dense collagenous tissue. This tissue 
contains bundles o f  collagen fibrils, elastic fibers, fibroblasts and a few smooth muscle 
cells. Next to the adventitia lies the media. The media consists o f spiraling layers of 
smooth muscle cells forming a muscular tube. This tube allows for chemical and neural 
regulation o f vessel diameter. The innermost layer of an artery, the intima, is composed 
primarily o f connective tissue, but also has smooth muscle cells scattered throughout. A 
single layer o f endothelium separates the intimai layer fi'om the bloodstream.*
The coronary arterial vasculature begins as it branches off the aorta close to its 
origin fi'om the left ventricle. The major vessels that are evaluated for CAD include the 
left main trunk, left anterior descending, left circumflex and right coronary arteries. Due 
to developmental variation, the inferior wall o f  the left ventricle receives its blood supply 
fi'om the posterior descending artery which may branch off from either the right coronary 
artery or left coronary artery. This is referred to as right or left dominance, respectively. 
Determining which system is dominant becomes an important factor when locating the 
culprit lesion responsible for an inferior wall AMI.“
Development o f Atherosclerosis 
The Response-to-Injury Hypothesis was first introduced in 1973.""* It has been 
modified over the years because of new research findings. However, its basic premise 
still stands; injury to the endothelial layer lining the intima causes endothelial cell 
dysfunction which initiates a sequence of events leading to the development of 
atherosclerotic lesions. This theory proposes that injury may be initiated by any one of 
the following: chronic hyperlipidemia, mechanical forces (ie. hypertension), 
homocysteinemia, the immune system, bacteria or viruses.’
Whatever the mechanism of injury may be, the proposed sequence o f events 
remains the same. When endothelial cells are injured, there are an increased number of 
adhesion molecules expressed on their surface. This results in an increased number of 
low density lipoproteins (LDL) and monocytes migrating through the endothelium into 
the intima. Once inside the intimai layer, monocytes are converted to macrophages and 
function as scavenger cells. As LDLs are internalized, they undergo a process o f low 
level oxidation. These newly oxidized LDLs (OxLDL) are viewed as foreign by the 
newly present macrophages. The macrophages take up the OxLDL in large quantities 
and become so engorged with lipids that when they are viewed microscopically, they take 
on the appearance o f foam. Researchers refer to these as foam cells when they reach this 
state.'®
As macrophages bind OxLDL, they become activated and secrete substances such 
as growth factors and toxic substances. Damaged endothelial cells also release growth 
factors. Growth factors stimulate the movement o f smooth muscle cells into the intima 
fi'om the media as well as growth of connective tissue. Toxic metabolic products
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released by activated macrophages damage the endothelium and contribute to further 
propagate the response to injury cycle. Once the injuring mechanisms are put into action, 
AS begins to follow a well documented pattern o f development.^
Progression o f Atherosclerosis 
The Response-to-Injury Hypothesis was formulated to explain the initiating 
mechanisms o f AS. The progression of AS, however, has been divided into six stages. 
The earliest manifestation o f atherosclerosis is the appearance of a fatty lesion or 
“streak.” These streaks can be found in infants and young children and are composed of 
foam cells and lipids within the intima. They appear grossly as yellow discolorations on 
the walls o f arteries and are considered prearthromatous lesions. These intimai lesions 
usually do not contain smooth muscle cells and the overlying endothelium remains 
intact.*
Stages I and II o f AS classify the progression o f fatty streaks as they accumulate 
large amounts o f lipids and macrophages in the subendothelium. As lesions advance to 
stage m , extracellular lipids begin to pool within the intima. However, at this stage, a 
single lipid core is not evident and necrotic cell debris and cholesterol crystals are 
absent.* Diffuse intimai thickening is characteristic o f  type IV lesions. This thickening, 
according to the Response-to-Injury Hypothesis, is the result of growth factors released 
by macrophages and endothelial cells causing connective tissue hyperplasia. These 
fibrous plaques may begin in the third decade o f life and progress with age. Located 
within a fibrous plaque is a central core o f extracellular lipids and necrotic cellular debris. 
This arthromatous substance is covered by a fibromuscular cap composed of connective
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tissue, macrophages and smooth muscle cells. At this point, the plaque is much thicker 
than the normal intima and bulges into the arterial lumen. ^
Type V and VI lesions are referred to as advanced or complicated lesions. They 
are calcified fibrotic plaques undergoing various degrees o f ulceration, thrombosis and 
necrosis. These plaques can also vary in their contents. Some advanced lesions contain 
little lipid and are rigid and sclerotic; others are rich in lipid contents and have only a thin 
fibrous cap. Advanced or “complex” lesions produce symptoms when they fissure or 
break open and their thrombogenic substances are exposed.
Plaque Rupture
Plaque rupture fi'equently occurs in advanced atherosclerotic lesions. When a 
plaque ruptures, its thrombogenic contents are exposed resulting in platelet adherence and 
stimulation of the coagulation pathway. The thrombus formed may be incorporated into 
the plaque itself, further contributing to its enlargement, or can partially or completely 
obstruct the arterial lumen, thus blocking distal blood flow. When the blood supply is 
impaired or reduced to distal tissues, cell ischemia and/or death occur if the blood supply 
is not quickly restored. If this occurs in a major vessel o f the coronary tree, the portion of 
the myocardium that it supplies will become ischemic and may die. However, the body’s 
own fibrinolytic processes may be successful ai restoring blood flow or the thrombus 
may occlude only a small portion of the arterial lumen still allowing some blood flow to 
the myocardium.^*
Recent studies propose that plaque disruption is responsible for as many as 75% 
of thrombi which cause unstable angina, AMI and sudden cardiac death.^'^’^ '^  The
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following paragraphs outline the current data about plaques which are prone to rupture 
and the factors which may “trigger” such disruption.
In an article reviewing recent data regarding plaque disruption, Kirstensen, et al.^ 
state “the risk o f plaque disruption depends more on plaque type (composition) than on 
plaque size and stenosis severity.” This review lists three known factors that determine a 
plaques’ vulnerability to rupture; core size, cap thickness and cap inflammation and 
repair. In his review of the pathogenesis o f coronary syndromes, Shah^ also cited these 
same three factors as determinants o f plaque disruption.
Plaques which have a large core o f lipids are at greater risk for rupture.^** In a 
study done by Uchida, et al.^ which examined plaques by angioscopy, it was discovered 
that glistening yellow plaques, those with a large lipid core, were associated with acute 
coronary syndromes more frequently than white plaques, those with predominantly 
fibrous content. Secondly, plaques with a thin fibrous cap have been shown to be at 
greater risk for rupture because o f  their susceptibility to mechanical forces, such as shear 
stress and turbulent blood flow."’ Finally, those plaques with increased inflammatory 
activity appear to be more prone to rupture. This is most likely due to the progressive 
internal damage within the plaque by proteolytic enzymes. These enzymes are released 
by activated macrophages within the plaque which weaken the cap, predisposing it to 
rupture."
Falk® suggests that stability, vulnerability and the presence o f certain triggers 
contribute to plaque rupture. Stability refers to the amount o f lipid-rich material that is 
contained in the plaque. Vulnerability refers to the thickness of the fibrous cap. He 
describes triggers as specific stressors applied to the plaque, such as fluctuations in blood
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pressure, shear stress or cap tension. Additionally, Falk states that according to 
Laplace’s Law, blood pressure and luminal diameter are positively correlated with tensile 
stress. Therefore, those plaques which take up only a small amount o f the arterial lumen 
diameter may be subjected to greater stress than more occlusive ones. While vasospasm 
seems to be a logical cause o f plaque disruption, Falk cites the results o f several studies 
disproving this hypothesis.
Another suspected trigger of plaque rupture is sympathetic nervous system 
activity.®' '^ The circadian rhythm is a documented pattern o f sympathetic activity which 
leads to variations in heart rate, blood pressure and coronary blood flow throughout the 
day. Muller, et al.^' state that clinical evidence shows peak times for AMI correlate with 
surges in sympathetic activity occurring in the morning hours and that beta blockers have 
been shown to blunt this response. Falk* states that sympathetic variation alone may not 
be responsible for the high number o f morning AMI’s since fibrinolytic activity is low 
and platelet aggregation and blood viscosity are both increased in the morning. All o f 
these factors may contribute to a favorable setting for plaque rupture and clot formation.
Svmptoms o f Atherosclerosis 
Atherosclerosis in the coronary vasculature is the most common cause of 
ischemic heart disease. Ischemia occurs when there is an imbalance between the 
myocardial oxygen demand and blood supply. Depending on the rate o f progression o f 
AS and the myocardial response, different clinical syndromes may develop. These 
include various forms of angina pectoris, acute myocardial infarction, sudden cardiac 
death or ischemic heart disease with congestive heart failure.' For the purposes of this 
study, the first three require further explanation.
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Angina pectoris is a general term used to describe symptoms, typically as 
substemal chest pain caused by reversible myocardial ischemia. Angina pectoris can be 
broken down further into stable angina, unstable angina and Prinzmetal’s angina. More 
than one form may be present in the same patient.'
Stable angina pectoris, also known as typical angina, refers to episodic chest pain 
associated with exertion or other forms of stress. It is often associated with a fixed 
degree o f atherosclerotic narrowing in one or more o f the coronary arteries, which under 
normal, resting conditions doesn’t produce symptoms. However, with exercise or other 
conditions stressing the heart, the myocardial oxygen demand may not be met, thus 
producing the classic crushing substemal chest pain patients often describe.'
Unstable angina pectoris is characterized by an increased fi*equency of chest pain. 
These episodes, when compared to typical angina, are precipitated by progressively less 
exertion on the heart as well as an increase in intensity and duration o f the attack.
Unstable angina may be a more severe clinical sign indicating that more serious, 
potentially irreversible, myocardial ischemia may result. For this reason, this form of 
angina is also sometimes referred to as preinfarction angina. It usually is “induced by 
acute plaque change with superimposed partial thrombosis, distal embolization of the 
thrombus, and/or vasospasm.” '
A third form o f angina, Prinzmetal’s or variant angina, can occur. This type of 
angina occurs at rest and can even awaken a patient from sleep. Symptoms in this 
situation are associated with coronary artery spasm near an atherosclerotic plaque.'
Progression o f angina can lead to an AMI which may also occur in the absence o f 
previous clinical symptoms. The majority of AMI’s occur as a result o f coronary artery
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thrombosis which in turn produce a defined area o f myocardial necrosis caused by 
local ischemia.® The location of an AMI is determined by the site o f occlusion within the 
coronary vasculature. The size of the infarct depends on if  the occlusion was in a 
proximal or distal segment o f that artery. Occlusion o f  more proximal segments 
generally produce larger infarcts involving the full thickness of the myocardium.'
The final syndrome o f  coronary AS is sudden cardiac death. This is usually due 
to a large area o f necrosis in the myocardium. Patients may have had years of angina 
prior to their acute event or death may have been their first symptom of AS. Among 
these fatal cases, 50% die before they ever reach the hospital.'
Current Therapv for Coronarv Arterv Disease 
Risk factor reduction
Risk factor reduction continues to be the first-line management for atherosclerotic 
CAD. “...A risk factor is the trait that predicts the risk o f  development o f clinically 
significant disease within a population.”  ^ The risk factors for CAD include those which 
are constitutional, or unchangeable. These include age, gender and family history. Risk 
factors which are, to some point, modifiable include hyperlipidemia, hypertension, 
cigarette smoking and diabetes mellitus.' Diet modification, weight loss, exercise and 
smoking cessation are all components o f risk factor modification. If these measures fail 
to diminish or reverse the progression o f CAD, pharmacotherapy may be initiated.
Pharmacotherapy
Several classes o f medications are involved in the treatment of CAD. The drugs 
which have been shown to have some impact include aspirin, beta blockers, lipid 
lowering drugs, nitrates and calcium channel blockers.
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Aspirin therapy is important in those patients with known CAD. Aspirin 
irreversibly inhibits thromboxane A  ^dependent platelet aggregation. It has been shown
to reduce the incidence o f AMI in persons with unstable angina.^
Beta blockers have been shown to blunt the sympathetic surges associated with 
the circadian rhythm.^' These medications decrease the myocardial oxygen demand by 
decreasing heart rate, myocardial contractility and systemic blood pressure.^
Drugs used to decrease serum lipid levels include fibric acid derivatives, nicotinic 
acid, bile acid binding resins, HmG CoA reductase inhibitors, probucol and estrogen.
Each of these has its own unique mechanism of action. Those drugs which lower LDL 
while increasing high-density lipoproteins (HDL) are preferred. If  monotherapy fails to 
bring down the level o f serum lipids, a combination o f lipid lowering agents may be used.
Nitrates dilate the venous system which decreases the blood return to the heart. 
This in turn reduces the workload of the myocardium.'
Calcium channel blockers produce peripheral arterial vasodilation and coronary 
arterial dilation. This allows an increased oxygen supply to the myocardium and a 
decreased cardiac workload.'
Surgical intervention 
Coronary angiography is used to evaluate the patency o f  the coronary circulation. 
Percutaneous transluminal coronary angioplasty (PTCA) is directed at flow-limiting 
lesions in order to relieve angina or ischemia. A catheter with a small deflated balloon is 
inserted into a peripheral artery and threaded into the coronary circulation to the desired 
location. A sequence o f rapid inflation and deflation is used to diminish the obstruction 
of the targeted atherosclerotic plaque. It is currently indicated for AMI, stable or unstable
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angina, and objective signs o f  ischemia evidenced on stress imaging studies. 
Contraindications for PTCA include rapidly terminal disease o f  cardiac or other causes.^ 
PTCA has become a common procedure and without complications, requires a less than 
48 hour hospital stay. PTCA is not without its disadvantages, however. The balloon 
procedure may need to be repeated several different times or rarely during the procedure, 
the patient may require emergency bypass surgery.^
Surgical revascularization or coronary artery bypass grafting (CABG) has been 
used to treat ischemic heart disease for many years. In order to be a candidate for CABG, 
there must be clinical evidence o f ischemia, as well as an evaluation of the coronary 
circulation by angiography. The location o f  suspected occlusions is important when 
considering the type o f revascularization technique. A patients’ own saphenous vein or 
internal mammary artery may be used to bypass the lesion in the coronary artery. One or 
several grafts may be done at the same time depending on the extent o f the patients’ 
disease. This surgery is not without its’ risks either. Among several complications are 
post-operative bleeding, intraoperative or postoperative AMI and cerebral vascular 
accident (CVA). Despite the potential grave complications, several people benefit 
greatly from this surgery and are able to live better, more productive lives.^
Diagnostic Tests Used to Evaluate Coronarv Artery Disease 
There are a number o f  screening tests, diagnostic tests and procedures that can be 
done to evaluate CAD. However, each has its advantages, disadvantages and limitations 
to the usefulness of the information it provides. This portion o f the literature review will 
focus on the more common tests currently used for the evaluation o f CAD. These include
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electrocardiography, stress echocardiography, myocardial perfusion imaging and 
angiography.
Electrocardiography 
The electrocardiogram (ECG) is the most widely used diagnostic tool in the 
evaluation o f chest pain.'”’^  It is a graphic recording of the electrical activity of the heart. 
Electrocardiography is used as a screening tool, as a guide to therapeutic intervention and 
as a definitive diagnostic tool. The ECG is noninvasive, painless, relatively inexpensive, 
requires minimal patient cooperation and can be done quickly in a variety of settings.*
In fact, it is the most common screening test for the detection o f  CAD.* However, direct 
visualization o f the coronary vasculature cannot be accomplished with this technique. If 
abnormalities are observed on the ECG, further diagnostic studies are undergone to 
assess the severity o f CAD.
The ECG may detect cardiac arrhythmias, conduction disturbances, myocardial 
ischemia, or increased susceptibility to sudden cardiac death.* Therefore, it is used 
primarily to diagnose and treat diseases o f the heart, but it is also used to detect certain 
pulmonary and extracardiac events, such as life-threatening metabolic disturbances.^-
Stress echocardiography 
A functional diagnostic test useful in identifying the extent and location of CAD 
is stress echocardiography.'” '  ^ Additionally, it can be used for pre-operative clearance 
and to determine a need for further cardiac testing.'” Stress echocardiography can be 
accomplished by using either a treadmill in patients who can tolerate physical activity or 
by using dobutamine or dipryridamole in patients who can’t.
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The stress echocardiogram using a treadmill is done in combination with 
standard two-dimensional (2-D) echocardiography. A baseline ECG, blood pressure and 
2-D echocardiogram are obtained prior to exercise. The patient then proceeds to stress 
the heart to peak stress by running or walking on a treadmill. Once exercise is stopped, a 
second 2-D echocardiogram is obtained. Once heart rate and blood pressure return to 
baseline, a post-stress 2-D echocardiogram is obtained. Comparisons are then made 
between the echocardiograms to determine the extent and location o f  CAD °
Patients requiring evaluation o f  known or suspected CAD but are unable to 
perform an adequate exercise test are candidates for a stress echocardiogram using 
dobutamine to stress the heart.'^ Dobutamine causes a relative ischemia by increasing 
heart rate and myocardial wall tension, therefore increasing myocardial oxygen 
d e m a n d . P a t i e n t s  receive a stepwise infusion o f dobutamine (5-lOpg/kg/min) until a 
peak dose is reached (30-40|ig/kg/min). An ECG, 2-D echocardiogram and blood 
pressure are done at every dose increase. Infusion is terminated if the patient experiences 
angina, severe arrhythmias or a 1mm ST segment depression appears on ECG.'°
Some o f the advantages o f “pharmacological” stress over exercise include the 
elimination o f respiratory artifact often present with physical exercise, immediate results, 
availability at patient bedside, and the ability to assess both global and regional 
myocardial function.'” '^  '* The extent o f stress-induced wall motion abnormalities 
correlate with the extent of angiographic disease.'"*
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Despite its potential advantages regarding cost and time efficiency, stress 
echocardiography has some significant limitations: up to 30% of patients do not have 
adequate acoustic windows and image interpretation is highly observer dependent.^
Myocardial perfusion imaging
Myocardial perfusion imaging is another diagnostic test used in the evaluation of 
CAD It is used to study the health and function o f the myocardium by indicating the 
actual coronary blood supply to the heart muscle and myocardial viability from all 
vessels, thus showing the true state of health o f the myocardium. Common indications 
for myocardial perfusion imaging include screening o f suspected CAD, evaluating heart 
function in known CAD and less commonly, for evaluation o f any other disease causing 
functional changes in the myocardium. It may also be useful in detecting an AMI, even 
within the first 24 hours."
The most commonly used agent in myocardial perfusion imaging is thallium-201 
(Ti-oi) 5 Y|2o. ^ radioactive isotope which chemically resembles potassium and its
biological properties. Approximately 88% of Tl‘°‘ “offered” to healthy myocardial cells 
is taken up by them. ° Two factors which influence the myocardial uptake of Tl*”* 
include the viability o f the myocardial tissue and the magnitude o f regional myocardial 
perfusion.^^
The procedure itself is noninvasive,performed with relative ease and generally 
well tolerated. Tl^°' is injected into the bloodstream and will be readily taken up by 
healthy myocardial cells which have active transport across their cell membranes. Those 
regions of the myocardium which show homogenous distribution o f activity are 
considered normal. Areas of ischemia due to restricted coronary artery flow have
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damaged cell functions and take up T1 more slowly and in smaller amounts. Tissue 
which has been infarcted will not take up any Tl^* at all. "
Typically, an initial scan is done when the Tl” ‘ is injected. A repeat scan is 
usually performed approximately three or four hours later because regions with restricted 
blood flow may eventually “fill in” with T l^ \ since it has a half life o f  73 hours. This is 
defined as redistribution.* '" If a Tl^‘ imaging scan reveals redistribution, patients may 
then be categorized as having a low or high risk o f subsequent myocardial infarction 
based on the presence and size of the redistribution. "
Thallium scans can be performed at rest, with exercise or both. It is standard 
practice to perform a two-part test with both rest and exercise components. The resting 
TI^' scan alone is less sensitive in detecting CAD in those patients with only activity- or 
exercise-induced angina. However, in patients who have anginal symptoms at rest, a 
resting Tl*"' scan is usually only needed. In addition, certain patients that would benefit 
fi'om both the resting and exercise scans may not be able to tolerate physical activity 
because of certain medical conditions or age. In this situation, a vasodilator, such as 
dipyridamole or adenosine, may be given just before Tf"' injection to induce maximal 
dilation of the coronary artery beds, which normally occurs during exercise. "
In a meta-analysis of 122 studies done by Kotler and Diamond,”  they report 
sensitivity ranges between 68% to 96% (average, 84%) and specificity ranges between 
65% to 100% (average, 87%) for exercise Tl” ' imaging used for the diagnosis of CAD. 
Additionally, when compared to exercise electrocardiography, exercise Tl” ' scanning 
increases the sensitivity for detection of CAD fi'om 60% to 80% and increases the 
specificity fi'om 80% to 90%.* However, felse positives have been reported in patients
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with cardiomyopathies, valvular disease, hypertension, left ventricular hypertrophy, 
hypertrophic subaortic stenosis, diabetes mellitus and various other medical conditions. " 
In addition to Tl^', technetium (To 99m) sestamibi can also be used in myocardial 
perfusion imaging studies. Tc 99m sestamibi is a radioactive tracer used in nuclear 
medicine scans and is similar to Tl^°' in rest, exercise and vasodilator drug scans because 
it collects in healthy myocardial cells." This combination is more useful in evaluating 
CAD than the former combination. Although the mechanism o f technetium Tc 99m 
sestamibi is not well understood, it provides more detailed perfusion images and seems to 
allow better visualization o f the right ventricle.'"
In conclusion, myocardial perfusion imaging provides a noninvasive and well- 
tolerated assessment o f CAD. Use of Tl^°* or technetium Tc 99m sestamibi improves 
localization o f ischemia and provides prognostic information since the presence and 
number of redistributing defects correlate with the incidence of future cardiac events.^ 
However, this type o f cardiac imaging, as indicated by the study mentioned above, may 
be limited in some patients by various medical conditions, such as diabetes mellitus and 
hypertension, resulting in false positive results.
Angiography
Coronary angiography is the standard clinical tool for evaluating patients with 
CAD.  ^ Additionally, for more than two decades, the coronary angiogram has been the 
standard on which major clinical decisions have been based, as well as the standard to 
compare the accuracy o f other tests used in the diagnosis of CAD.”
Angiographic assessment o f the coronary arteries can be performed for many 
reasons. One o f the most common indications is to determine the degree o f  CAD in
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patients with angina pectoris. Others include confirmation o f the presence o f  variant 
angina, assessment o f myocardial infarction complications, as well as further evaluation 
o f positive cardiac stress tests. Angiography also serves as a guide for medical and/or 
surgical management o f  cardiac patients.* '”
Coronary angiography involves the placement o f a catheter under fluoroscopy 
through the aorta into the left and right coronary arteries. Several injections o f 
radioopaque contrast dye are given so that the anatomy and patency o f the coronary 
arteries can be viewed. Individual coronary arteries and their branches are injected 
separately and viewed from different angles so that the entire coronary artery circulation 
may be visualized. A disadvantage o f this procedure is that it cannot be used to evaluate 
the lumen in cross-section and does not provide and image of the arterial wall unless 
calcification is present.
Once coronary angiography has been performed, many clinical decisions are 
based on the severity o f  coronary artery obstruction. This is usually estimated visually in 
terms of “percent stenosis.”’ A majority of the current literature evaluating CAD 
distinguishes between severity o f lesions by referring to them as “non-significant” or 
“significant” stenosis. Non-significant stenoses are those which occlude <50% of the 
arterial lumen and significant stenoses occlude >50% of the arterial l u m e n . H o w e v e r ,  
a fundamental assumption in the evaluation o f “percent stenosis” is that the 
angiographically “normal” segment of the coronary artery adjacent to the lesion is free of 
atherosclerotic disease.’
Although coronary angiography is a widely used and accepted form o f CAD 
evaluation, current research suggests some limitations on its use. In a postmortem study
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done by McPherson, et al., their results “...demonstrate that diffuse coronary 
atherosclerosis is often present when coronary angiography reveals only discrete 
stenosis,” suggesting that “coronary angiography may underestimate the severity and 
extent of coronary disease.” As a consequence, measurements o f “percent stenosis” often 
do not correlate with the physiologic importance o f a lesion. Additionally, in a study 
done by Little, et al.,‘* their findings suggest that “coronary angiography may 
underestimate the extent o f coronary atherosclerosis and that an abnormality in 
endothelial function that may help promote thrombus production can exist in coronary 
arteries that do not contain an angiographically significant stenosis.” In yet another 
study. Little^ concluded that “...lack of apparent stenosis in an arterial segment does not 
necessarily indicate that the segment is free from atherosclerosis, particularly if stenotic 
lesions are present elsewhere in the coronary arteries.”
Based on the findings in the above-mentioned studies, it has not been determined 
if  coronary angiography can accurately predict the site o f a subsequent coronary artery 
occlusion that will produce an AMI. Therefore, it is unlikely that therapy aimed only at 
sites of angiographic coronary obstruction will be effective in preventing future AMI’s.
Mvocardial Infarction and Arterial Stenosis 
Plaque rupture and acute thrombosis are responsible for the majority of acute 
coronary events.^'^'^'^" Determining which plaques have the potential to rupture and 
thrombose is very important. It is known which factors make plaques vulnerable to 
rupture.^'^ However, predicting which plaques co-existing in the same coronary artery 
will rupture and which o f those that will not is a bit more challenging. Little is known 
about preexisting arterial stenosis in an infarct related artery.^
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Coronary angiography is a tool used to evaluate the severity o f  CAD 
However, it is limited by its inability to provide information about the components of 
plaques. Plaques are evaluated by the extent to which they occlude the arterial lumen 
rather than their composition. Plaques defined as non-significant stenoses are those 
which occlude <50% of the arterial lumen and significant stenoses are those occluding 
>50% of the arterial lumen.’" Several studies’"''*’'  ^have attempted to correlate the future 
site o f a subsequent AMI in those arteries which had significant stenosis identified on 
prior angiography.
Little, et al.’* evaluated 29 patients with mild to moderate CAD who experienced 
an AMI with coronary angiography done both before and after the event. The second 
angiogram was used to determine which plaque was responsible for the AMI. Analysis 
of data revealed that in 19 patients (66%), the culprit lesion was <50% occlusive. In 
addition, the culprit lesion was <70% occlusive in 28 patients (98%). They concluded 
that AMI occurred in arteries containing the most severe stenosis on initial angiography. 
In the majority (66%) of these patients, though, the occlusion was originally <50% of the 
arterial lumen.
Similar results are reported in a retrospective study done by Giroud, et al.,’^  where 
92 patients who had coronary angiograms performed prior to and after an AMI The 
arterial segment responsible for the subsequent AMI occluded the arterial lumen by 
>50% on the initial angiogram in only 20 of the 92 patients (22%). Upon examination of 
the second angiogram, it was discovered that 32% of the AMI’s were the result o f 
rupturing by the most severely stenosed artery. It was also found that the stenosis in the 
culprit segment was of a higher degree in the first arteriogram when the time between the
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first film and the AMI was shorter (p = 0.04). In conclusion, the authors reported that 
the severity o f arterial narrowing was a poor predictor o f subsequent AMI.
Ambrose, et al.'^ performed a retrospective analysis o f two groups totaling 38 
patients. Group I consisted o f 23 patients who had an AMI with coronary angiography 
performed both before and after the event. Group II consisted o f 15 patients who had one 
or more new total occlusions at the time of the second study without suffering an AMI. 
Thirty percent o f those patients who had an AMI had a normal appearing culprit coronary 
segment on initial angiography. Eleven (48%) o f 23 lesions in Group I were responsible 
for <50% occlusion and 5 (22%) o f 23 lesions were causing >70% stenosis. In Group n,
6 (33%) o f 18 lesions were responsible for <50% occlusion and 11 (61%) of 18 lesions 
were causing >70% stenosis. They discovered that “these differences between Group I 
and n  in the percent stenosis on initial angiography o f the lesions were the site of 
infarction or new total occlusion at restudy were clinically significant (p<0.05).” This 
group o f researchers concluded that “...one cannot predict the location of a subsequent 
infarction from analysis o f  a previous angiogram” and that “myocardial infarction 
appears to develop frequently from a coronary lesion that was less than severe on prior 
angiography.”
Patients with ischemic heart disease were studied by Nobuyoshi, et al.*° over a 13 
year period. These 239 patients underwent serial angiography at least twice and had a 
myocardial perfusion study done during the study period. Patients were divided into 
three groups according to the progression of their CAD between angiograms. Group I 
consisted of 39 patients who had had an AMI. Group II consisted o f 90 patients who had 
CAD progression in the absence o f AMI. Group HI consisted o f 110 patients who had no
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CAD progression. In 23 o f 39 (59%) patients in Group I, arterial segments which were 
<50% occluded were responsible for the AMI. This study concluded the “...mild stenosis 
was often the site of acute occlusion leading to myocardial infarction.”
Hackett, et al.*' studied the angiograms of 60 patients who presented with an AMI 
and received successful intracoronary thrombolytic therapy. The authors examined the 
severity of the residual coronary stenoses. Patients underwent angiography before, 
during and after therapy. The researchers found that “a residual stenosis of less than 60% 
was present in 28 (47%) of patients and less than 50% in 12 (20%).” Although the 
authors admitted that measuring residual stenosis immediately after thrombolysis is likely 
to lead to overestimation o f stenosis severity, they do believe that at least 26% and 
perhaps more of the patients in their study “...have preexisting infarct-related coronary 
stenoses of less than 60% obstruction diameter.”
Ambrose,'* Little,'* Hackett,*' Nobuyoshi^" and Giroud'^ suggested in their studies 
that non-significant stenoses (<50%) are responsible for a large number of AMI’s than 
previously thought. These studies also agreed that the location o f subsequent AMI 
cannot be predicted by angiography. Ambrose, et al.'^ found that 30% of those in the 
study who had an AMI had normal appearing arteries on previous angiography. This 
raises the concern that there may be a portion of the population with asymptomatic, 
undetectable, atherosclerotic plaques at risk for AMI. Further studies are needed to 
determine the significance that these data holds for the rest o f the population.
Conclusion
Atherosclerotic CAD is a major health problem in the United States. Its 
development is insidious over many years. Its sequelae o f  angina pectoris, myocardial
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infarction, and sudden cardiac death consume a  large amount o f health care dollars and 
are responsible for a great deal o f human suffering. Medicine has a responsibility to 
develop adequate screening techniques and therapeutic interventions to treat this 
significant problem. Additionally, according to  the studies reviewed above, a large 
portion of those with from CAD are at risk for an AMI. Therefore, continual evaluation 
of the currently accepted diagnostic tools and treatment goals for CAD is warranted.
CHAPTERS
METHODOLOGY
Study Design
The design of this study was a retrospective cohort design involving patients who 
experienced an acute myocardial infarction (AMI) or had diagnostic coronary 
angiography between January 1, 1995, and December 31, 1998.
Study Site and Subjects
The study was conducted at the offices o f Grand River Cardiology, PC., 1000 
East Paris SE, Grand Rapids, MI, 49546. Subjects were identified from the medical 
records at Grand River Cardiology, P C ,  based on a diagnosis code o f “acute myocardial 
infarction” (410.0 - 410.9) using the 1998 International Classification o f Diseases, 9th 
Revision, Clinical Modification, Fifth Edition (ICD-9-CM), or a procedure code of “left 
heart catheterization, retrograde, from the brachial artery, axillary artery or femoral 
artery; percutaneous” (93510) using the 1998 Physician’s Current Procedural 
Terminology. Either the acute myocardial infarction or the left heart catheterization must 
have occurred between January 1, 1995, through December 31, 1998. The AMI may or 
may not have been the subjects’ first documented AMI.
After the initial selection o f study subjects, additional inclusion criteria were met. 
The first criterion required that the AMI must have been diagnosed based on at least two 
out of three of the following: typical cardiac ischemic pain lasting >30 minutes, 
persistent ST segment elevation typical o f AMI in >2 electrocardiogram (ECG) leads, or 
elevation o f serum creatine kinase levels to three times the normal limit. These criteria
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are the current acceptable standards for noninvasive diagnosis o f an The
second inclusion criterion stated that the subject had to have had a previous angiographic 
assessment o f the coronary vasculature prior to the AMI. This provided a baseline degree 
o f the patients’ existing coronary artery disease.
Once inclusion criteria were determined, one exclusion criterion was evaluated. 
This criterion excluded subjects who had their angiographic study done at any institution 
other than at Saint Mary’s Health Services, 200 Jefferson SE, Grand Rapids, MI, 49503.
Equipment and Instruments 
Coronary angiography is the standard clinical tool to evaluate the coronary 
vasculature for CAD.’-’’ Therefore, the equipment used for the procedure, which has 
been approved by the Food and Drug Administration (FDA), is assumed to be accurate 
and valid by the researchers. The equipment used for coronary angiography is located at 
Saint Mary’s Health Services, 200 Jefferson SE, Grand Rapids, MI, 49503, in the 
radiology department where coronary angiograms are performed.
A caliper was used during angiographic assessment to measure stenotic areas in 
the left main trunk, left anterior descending, left circumflex and right coronary artery by 
comparing them to the nearest adjacent normal arterial segment in that same artery. A 
fundamental assumption in the evaluation of “percent stenosis” is that the 
angiographically “normal” segment o f the coronary artery adjacent to the lesion is free of 
atherosclerotic disease.’
Subjects’ medical records were located at the office of Grand River Cardiology, 
P C ,  where the data collection took place. Subjects were not directly involved in the 
study; only medical record data were used. The researchers involved in this study have
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completed patient confidentiality meetings and have signed a “Confidentiality 
Statement for Research Studies” form (see Appendix A).
The Subject Data Form (see Appendix B) was used as a guide when reviewing all 
charts. Inclusion and exclusion criteria mentioned above were met with this form. 
Subjects who met the study criteria were assigned a number in order to eliminate their 
names from the Subject Data Form. However, a Subject Data Form Master List (see 
Appendix C), which included each subjects’ assigned number, name and date of birth, 
was kept so that angiograms could be found for each subject at Saint Mary’s Health 
Services. Angiograms were then reviewed and significant data recorded on the 
appropriate Subject Data Form.
Validitv/Reliabilitv
In order to eliminate concerns related to interrater reliability, Gregory L. Miller, 
M.D., F. A.C.C., a physician at Grand River Cardiology, P C., interpreted all angiograms.
Procedure
Subjects o f this study were patients from the office of Grand River Cardiology, 
P C , in Grand Rapids, MI. Initially, all medical records were screened and a list was 
compiled o f all patients who had either an AMI since January 1, 1995, based on a 
diagnosis code o f acute myocardial infarction (410.0 - 410.9) using the 1998 International 
Classification o f Diseases, 9th Revision, Clinical Modification, Fifth Edition (ICD-9- 
CM) or a procedure code of “left heart catheterization, retrograde, from the brachial 
artery, axillary artery or femoral artery; percutaneous” (93510) using the 1998 
Physician’s Current Procedural Terminology. From this list, the Subject Data Form was 
used to review the medical records o f all potential subjects. The data were collected from
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medical records during the months starting December 1, 1998, through January, 1999, 
by going through selected records and recording applicable data on the Subject Data 
Form. This was done by the researchers Brandi Haik and Amy Schreur.
Once all data were collected. Dr. Miller reviewed the subjects’ coronary 
angiograms at Saint Mary’s Health Services in Grand Rapids, MI. Dr. NÆller, without 
prior knowledge of the official angiography results or which vessel was responsible for 
the AMI, used a caliper to measure, in millimeters, lumen diameter at the point of 
maximal stenosis of an artery, as well as that arterial segment which appeared to be 
normal. These data were then converted into a percentage to represent the degree of 
coronary arterial occlusion. This was done by dividing the narrowest portion of 
occlusion by the nearest normal-appearing portion of that same artery, multiplying by one 
hundred and rounding to the nearest fifth percentage. The four arteries evaluated 
included the left main trunk, left anterior descending, left circumflex and the right 
coronary artery. Additionally, the dominance, right or left, o f coronary arterial 
circulation was determined by identifying which artery the posterior descending artery 
originated from in patients who had an inferior AMI. This information was recorded on 
the Subject Data Form in the Angiography section.
All Subject Data Forms were collected and kept in a manila envelope throughout 
the study period. The Subject Data Form Master List was kept in a separate envelope and 
stored at the office o f Grand River Cardiology, P C ,  during the study period, except 
when reviewing angiograms at Saint Mary’s Health Services. After the conclusion o f the 
study, the Subject Data Forms and Subject Data Form Master List are and will be kept in 
the offices o f Grand River Cardiology, P C ,  for a period of three years.
CHAPTER4 
ANALYSIS OF DATA
Techniques o f  Data Analysis 
Ten subjects met the inclusion criteria o f this study; however, because ten is a 
small sample, statistical analysis is difficult. Therefore, descriptive analysis will be used 
to attempt to identify relationships between variables identified in this study for each o f 
the ten subjects included.
Subject Characteristics 
Three hundred and eighty-four subjects were selected based on the initial study 
criteria. Following medical record review, 374 subjects were excluded for the following 
reasons: 256 had not had a subsequent AMI; 112 had angiography after the AMI 
occurred; 3 did not meet the two out three criteria for an AMI diagnosis; and 3 underwent 
angiography at an institution other than Saint Mary’s Health Services.
With the remaining 10 subjects, various risk factors were evaluated and are 
presented in Table 1 below. Additionally, the subjects were divided into two groups. 
Group I consists o f six subjects (60%) who were found to have an AMI in vessels with 
<50% occlusion identified on previous angiography. The four subjects (40%) in Group II 
include those who had >50% occlusion identified on prior angiography in the infarct 
related artery.
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Table 1
Subject Risk Factors
All Subjects 
fn = 101
Group I (<50%)
In = 6)
Group n  (>50%) 
(n = 4)
Mean Age (yr) 
Sex
67 (SD= 11.20) 63 73
Male 7 4 3
Female 3 2 1
Diabetes Mellitus 2 I 1
Family History of CAD 8 4 4
Hypertension 7 5 2
Tobacco Use
CAD = coronary arterv disease
4 4 0
It is interesting to note the incidence of risk factors between Group I and Group U. 
Two of the risk factors evaluated in this study, diabetes mellitus and positive family 
history o f coronary artery disease (CAD), have an equal distribution between the two 
groups. However, of the seven subjects who have hypertension, five (71%) of them fell 
into Group I. Additionally, all four subjects (100%) with a history o f tobacco abuse were 
placed into Group I as well.
Indications for angiography varied for the subjects in this study. Four of the 
subjects (40%) had unstable angina, two of the subjects (20%) had stable angina, and the 
remaining subjects had various other indications. These included shortness of breath, 
determination of appropriate interventions and for diagnostic purposes.
In six o f our 10 subjects, the artery with the maximal amount o f occlusion 
identified on angiography was responsible for three (50%) o f the subsequent AMI’s. In
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the other three subjects, the artery with the culprit lesion was not the artery identified 
as having maximum stenosis in that subject on angiography. Furthermore, two of the six 
subjects (33%) had an AMI in a vessel with <50% occlusion identified on angiography. 
These data are presented below in Table 2.
Table 2
Percentage o f Maximal Stenosis and Actual Percentage in 
Culprit Arterv Responsible for AMI in Patients Without Surgical Intervention
Patient No.
Maximum stenosis 
on aneioeram
Percent stenosis of 
culorit lesion Location of AMI
3 100 85 inferior
4 60 10 anteroseptai
5 90 90 inferior
6 0 0 anterior
8 100 100 inferior
9 100 100 inferolateral
As stated previously, six o f the subjects (60%) were found to have an AMI in 
vessels with <50% occlusion previously identified on angiography. Of these six subjects, 
four (66%) received surgical intervention as treatment for their CAD prior to the AMI. 
Three of these six subjects underwent percutaneous transluminal coronary angioplasty 
(PTCA) after their initial angiogram. One subject underwent coronary artery bypass 
grafting (C ABG) prior to their angiogram. Despite these surgical interventions, the 
angioplastic and bypassed vessels were responsible for the subsequent AMI in each o f 
these subjects. The actual percentage of occlusion due to the culprit lesion at the time of 
AMI in subjects receiving PTCA is unable to accurately be determined because post­
intervention stenosis is not routinely identified. The subject with prior CABG had a 
patent saphenous vein graft in the culprit artery on angiography. Therefore, for purposes
of this study, the culprit lesion is assumed to present with <50% occlusion at the time 
of infarction. These data are presented in Table 3 below.
Table 3
Percentage of Maximal Stenosis and Actual Percentage in 
Culprit Arterv Responsible for AMI in Patients With Surgical Intervention
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Patient No.
Maximum stenosis 
on aneioeram
Percent stenosis of 
culorit lesion Location of AMI
I 80 ? inferior
2 95 ? anterior
7 95 <50% inferoposterior
10 80 ? inferoposterior
The time interval, in months, between the date o f angiography and the date the 
subject presented with AMI was compared between Group I and Group II mentioned 
above. The results are listed in Table 4 below 
Table 4
Time in Months Between Angiography and AMI
All Subjects 
In = 101
Group I (<50%) 
In = 61
Group n  (>50%) 
In = 41
Subject Number
I 57 57
2 4 4
3 6 6
4 6 6*
5 27 27
6 7 7
7 20 20*
8 30 30
9 2 2
10 57 57
Mean 21.6 25.2 16.3
* = without sureical intervention
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The range for number o f months between angiography and subsequent AMI for 
ail subjects was between 2 and 57 months with a mean o f 21.6 months. Those subjects in 
Group I had a mean greater than the total number of subjects. However, two (33%) of 
the six subjects (subject numbers 4 & 6) who did not receive surgical intervention had a 
mean o f 6.5 months. Additionally, these subjects had only had 10% and 0% stenosis on 
angiography in the culprit artery. Subjects in Group U had a mean o f  16.3 months, lower 
than that o f the total group.
Group I and Group II were again compared to determine whether there was a 
difference between their medications at the time of the AMI. The medications identified 
in this study are currently indicated for the treatment of symptoms and to slow or reverse 
the progression o f  CAD. These include aspirin, beta blockers, HmG Co A reductase 
inhibitors, nitrates and calcium channel blockers. Again, presented in Table 5, all 
subjects were represented, as well as a breakdown of medications taken by subjects in 
both Group I and Group II.
Table 5
Medications at Time of AMI
All Subjects 
in = 10)
Group I (<50%)
fn = 6)
Group n  (>50%) 
In = 4)
Aspirin 5 3 2
Beta Blockers 5 3 2
HmG CoA Reductase 
Inhibitors 4 2 2
Nitrates 3 2 1
Calcium Channel Blockers 4 2 2
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This study found that no greater than 50% of subjects were on any one of the 
medications that have been indicated for the treatment o f symptoms and to slow or 
reverse the progression o f  CAD. Only 50% were on either aspirin or beta blockers, 40% 
on a cholesterol-reducing medication, 30% on nitrates and 40% on calcium channel 
blockers. Additionally, there was no identifiable relationship between Group I and II 
with any o f the medications and incidence of subsequent AMI.
The following table (Table 6) breaks down medications at the time o f  AMI for 
each subject, along with the number of months between the angiogram and AMI.
Table 6
Medications at Time of AMI vs. Months Between Aneiographv and AMI
ASA BB HmG CoA RI Nitrates CCB Months
Subject
Number;
I N N N N N 57
2 Y Y N N N 4
3 Y N Y N N 6
4 N Y Y N Y 6
5 Y Y Y N N 27
6 Y Y N Y N 7
7 N N Y Y Y 20
8 N Y N N Y 30
9 N N N Y Y 2
10 Y N N N N 57
ASA=asDirin: BB=beta blockers; CCB=calcium channel blockers
When reviewing Table 6, there isn’t any obvious correlation between the 
medications at the time o f  AMI and the amount o f time between angiography and AMI. 
However, it is worth noting that two of the subjects (20%) had the identical scenario with 
the exception o f one subject taking aspirin on a daily basis at the time o f AMI. Subject 
number one had an 80% occlusion on angiography, underwent PTCA and was not taking
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any medication at the time o f the AMI 57 months later. Similarly, subject number 10 
had 80% occlusion on angiography, underwent PTCA but still infarcted fifty-seven 
months later; however, this subject was taking aspirin.
Hvpothesis
Our hypothesis stated that myocardial infarction frequently occurs in coronary 
arteries with previously non-significant stenosis (<50%) identified on angiography. 
Although our study did not yield statistically significant data to uphold this hypothesis, 
the data still point to the fact that an AMI can occur in vessels with such non-significant 
lesions. Furthermore, it has been shown in the literature^ *'* that PTCA and CABG do not 
necessarily prevent future AMI’s in the surgically treated vessel. The data presented 
above in those subjects who had PTCA or CABG prior to their AMI support this 
observation as well.
CHAPTERS
DISCUSSION
Interpretation o f Findings
Although the results o f this study were not statistically significant due to the small 
sample, it did find that six out of ten subjects (60%) had an acute myocardial infarction 
(AMI) where the culprit lesion was <50% stenosed on prior angiography. These results 
are consistent with prior studies by Ambrose, et al.,‘^  Little, et al.,‘* Nobuyoshi, et al.“  
and Giroud, et al.‘®
Ambrose, et al.*^  found in their retrospective analysis o f 38 patients that 48% of 
their sample had culprit lesions causing <50% stenosis. Thirty percent had normal- 
appearing coronary arteries prior to AMI identified on angiography. Only five o f their 
patients (22%) had culprit lesions causing >70% stenosis. Little, et al.‘* found that of 
their 29 patients, 19 (66%) had culprit lesions causing <50% stenosis and 28 (98%) had 
culprit lesions with <70% stenosis. Nobuyoshi, et al.“  identified 39 patients who 
underwent angiography and subsequently had an AMI. O f these, 23 patients (59%) had 
lesions responsible for the AMI previously identified as causing <50% occlusion in the 
culprit artery. Giroud, et al.'® studied 92 patients with coronary angiography prior to and 
after a subsequent AMI. They found that the arterial segment responsible for the AMI 
occluded the arterial lumen by >50% in only 20 (22%) of the 92 patients.
Despite having received either percutaneous transluminal coronary angioplasty 
(PTCA) or coronary artery bypass grafting (CABG), four subjects (40%) in this study had
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progression of coronary artery disease (CAD) to AMI. This supports studies done by 
Little, et al.^ and Kerensky, et who concluded that PTCA and CABG did not
prevent future cardiac events in the surgically treated vessel.
22
Little, et al. found 57% o f AMI’s occurred in patients who previously had 
PTCA, but the AMI resulted in a vessel with an untreated lesion. Thirty-three percent o f 
AMI’s occurred after CABG, but from a stenosis in a non-bypassed artery. In two
23*24studies conducted by Kerensky, et al., the first noted 57% of AMI’s occurring more 
than two weeks after successful PTCA resulted from occlusions other than the 
angioplasty site. Similarly, in a second study, 64% of patients had occlusions in an 
untreated vessel.
The results o f this study identified four subjects with a history o f tobacco abuse. 
All o f these subjects were found to have a non-significant lesion in the culprit artery 
resulting in AMI Nicotine has been shown to induce arterial vasospasm^ and may have 
been a triggering event in the evolution of the AMI in these subjects.
Clinical Implications 
The results o f this study point to the fact that lesions considered non-significant 
(<50%) on prior angiography should also be addressed when determining CAD 
management. Lesions which do not warrant surgical intervention should still be treated 
medically to prevent a subsequent AMI.'*
Brown, et al.”  suggest two goals for optimal management of CAD. First, . to 
diminish the symptomatic limitations imposed by arterial obstructive disease.” This is 
accomplished by restoring the balance o f oxygen supply and demand to the myocardium
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via surgical intervention and plaque regression. In their article, studies are cited which 
have linked reductions in low-density lipoprotein (LDL) by lifestyle alterations and lipid- 
lowering medications to variable degrees of plaque regression. Furthermore, Brown and 
Fuster,^ state that “only about 12% o f all coronary lesions visibly regress (>10% stenosis 
change) with intensive lipid lowering.” Although there is evidence that plaque regression 
is possible,^^ additional studies are needed in order to provide sufficient data to establish 
plaque regression as a valid goal and accepted standard for CAD therapy.
The second goal suggested by Brown, et al.”  is “ . ..to prevent the anticipated 
worsening of symptoms or progression to clinical events such as sudden death, 
myocardial infarction or worsening angina... ” This goal can be achieved by plaque 
stabilization. Shah^ also suggests similar goals in his study. Both researchers suggest 
four ways to promote plaque stabilization. These include improving endothelial function; 
ensuring favorable thrombotic-thrombolytic equilibrium; eliminating triggering 
conditions or activities; and altering plaque composition.
Even though PTCA and CABG successfully restore oxygen supply and improve 
quality o f l i fe ,*o ther  known lesions elsewhere in the coronary vasculature should not 
be overlooked. This study revealed that despite surgical intervention, subjects still went 
on to have an AMI. Therefore, it is important for clinicians to consider the fact that 
regardless of surgical intervention, these patients remain at risk for subsequent AMI.
When reviewing medications taken by subjects included in this study at the time 
of AMI, there was no correlation found between medications and length o f time between 
angiography and AMI. Furthermore, the data did not reveal that one medication or
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combination of medications was able to prevent subsequent AMI in either those 
subjects with arteries having non-significant (<50%) or significant (>50%) coronary 
stenoses.
Limitations of the Studv 
The first, and probably most important, limitation of this study was the size o f the 
sample. With only ten subjects meeting inclusion criteria, it became difficult to conclude 
any significant statistical correlation between variables.
Although not necessarily a limitation, but rather a reason for the small sample 
size, the researchers conclude that the inclusion criteria may have been too strictly 
defined. O f the 374 medical records reviewed, the selection criteria automatically 
eliminated 112 subjects (30%) admitted with an AMI because o f the absence of an 
angiogram before infarction. This number is not surprising since many people who 
present to emergency rooms with their first AMI do not have a previous history o f pre­
infarction symptomology.^ Another 256 subjects (68%) had angiography, but did not 
have a subsequent AMI at the time o f this study.
In addition to the strict inclusion criteria, another reason for the small sample in 
this study involves evaluating subjects from only one cardiology practice. Not only did 
this limit the number of subjects who potentially could have been included in this study, 
it may have impacted the number and characteristics o f subjects who did receive 
angiography. Although there are solid indications for angiography,*•'“ some clinicians 
may utilize angiography more frequently for diagnostic purposes rather than other less 
invasive tests such as stress echocardiogram or myocardial perfusion imaging.
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Including only those subjects who had angiography performed at Saint Mary’s 
Health Services also limited our sample size as well. Subjects who had their angiogram 
done at another institution were excluded from this study. Although this did not exclude 
a significant number o f subjects, it did eliminate three. Furthermore, if these subjects had 
been included in our sample, they would not have made a considerable impact in our 
sample size to allow for statistical rather than descriptive analysis.
The lack o f quantitative measurement, other than the use o f a caliper, to estimate 
percent stenosis o f arteries on angiography may have affected results in this study. 
However, subjective evaluation o f coronary morphology is reasonably reproducible, and 
the estimated percentage o f the diameter of a stenosed artery remains the best simple 
clinical index to define the severity o f a coronary lesion.'®
Finally, coronary artery disease may have progressed significantly in those 
arteries that appeared to be non-significant (<50%) on angiography prior to subsequent 
AMI. Because o f the length o f time between angiography and AMI in some subjects, the 
degree of stenosis at the time o f  AMI may have been underestimated due to variable 
progression o f atherosclerosis.
Further Research
Based on the findings o f this study and others,'^'*'®’^ ' further research is warranted 
to attempt to conclude statistically significant results. Ideally, a larger sample size o f at 
least 100 subjects would yield higher accuracy and correlation o f results.
Additionally, further research could examine whether there is a significant 
difference in the incidence o f AMI in those subjects treated medically, and those subjects 
receiving either PTCA or CABG for treatment of symptomatic CAD.
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Further investigation may be done to determine if  coronary plaque morphology 
is related to the likelihood o f  plaque disruption, thrombosis and vessel occlusion leading 
to an AMI.
Finally, conducting a  prospective study using the same variables, rather than 
retrospective, may be o f greater benefit. This would enable the researchers to enroll 
subjects at the time o f initial angiography, implement and monitor drug regimens more 
effectively and identify modifiable risk factors.
Conclusion
Coronary artery disease and its sequelae has been shown to be an important cause 
of morbidity and mortality in the United States.' Although the sample size of this study 
limited the ability to draw statistically significant conclusions from the data, valuable 
observations have been made. Patients with prior history o f PTCA or CABG and those 
with non-significant (<50%) stenosis on angiography should not be considered to lack 
risk for AMI than those with significant (>50%) stenosis. This coincides with study 
findings of Ambrose,'* Little,'* Hackett,^' Nobuyoshi^ and Giroud'’ previously described.
Finally, risk factor reduction and pharmacological therapy aimed at the entire 
coronary tree in an effort to reduce symptoms, slow progression and stabilize plaques 
should be instituted in all patients identified with CAD to prevent future AMI.'*-^'* 
Furthermore, studies are needed to be able to accurately identify patients with 
asymptomatic CAD, and thus determine appropriate intervention in those patients to 
prevent angina pectoris, acute myocardial infarction or sudden death.
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Confidentiality Statement for Research Studies
In carrying out its mission. Saint Mary’s Health Services (SMHS) endeavors to improve the quality of 
patient care and the health status o f the community and to protect the confidentiality o f patients.
While Saint Mary’s seeks to achieve all of these goals to the fullest degree possible, it recognizes that 
at times these goals can be in conflict; improvement o f the quality o f  care and of health status require 
access to data; but such access can place at risk patient confidentiality.
Sensitive to the SMHS mission and to the conflicts that can arise, I understand that information is 
required for me to perform research. Some of this information may concern patients being treated at 
SMHS or it may concern the operations of SMHS. I understand that any patient medical information 
belongs to the patient and that I am only permitted to access patient medical information to the extent 
that it is necessary to conduct my researclL I also understand that all medical and personal 
information regarding patients is confidential and must not be revealed or discussed with other 
patients, fnends, or relatives, or anyone else within or outside the SMHS healthcare envirorunent.
I also understand that other information regarding the operations o f  SMHS is confidential. This 
information concerns employees, financial operations, quality assiuance, utilization review, risk 
management, research, procurement, contracting, credentialing o f staff and other provider 
information. I understand that I am only authorized to access this information if it is required for me 
to conduct my research. This information must not bè revealed or discussed with others within or 
outside o f  SMHS except to the extent that it is necessary to conduct my research.
I understand that I am required to protect any SMHS patient or operations information fi-om loss, 
misuse, unauthorized access, or unauthorized modification.
I agree to abide by all policies and procedures of SMHS as it relates to patient confidentiality, medical 
records, and research studies. No unauthorized copies o f data or records will be made or maintained.
I understand that failure to follow all policies regarding the confidentiality o f information is a cause 
for termination o f  contract with or revocation of access to SMHS and may subject me to potential 
civil or criminal liability.
tetOi^ dL SkLÙc______________ I0|a3|98_______
Signature Date
Manager, Clinical Information Services Date
October 2.1998
K:\Research\Research PaekefMEDREC.lVPD
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Confuli*ntiality Statement for Research Studies
In carrying out its mission. Saint Mary’s Health Services (SM H ^endeavors to improve the quality of 
patient care and the health status of the community and to proton the confidentiality of patients.
While Saint Mary’s seeks to achieve all of these goals to the fullest degree possible, it recognizes that 
at times these goals can be in conflict; improvement of the quality o f  care and of health status require 
access to data; but such access can place at risk patient confidentiality.
Sensitive to the SMHS mission and to the conflicts that can arise, I understand that information is 
required for me to perform research. Some o f this information may concern patients being treated at 
SMHS or it may concern the operations of SMHS. I understand that any patient medical information 
belongs to the patient and that I am only permitted to access patient medical information to the extent 
that it is necessary to conduct my research. I also understand that all medical and personal 
information regarding patients is confidential and must not be revealed or discussed with other 
patients, fnends, or relatives, or anyone else within or outside the SMHS healthcare environment.
I also understand that other information regarding the operations o f SMHS is confidential. This 
information concerns employees, financial operations, quality assurance, utilization review, risk 
management, research, procurement, contracting, credentialing o f  staff and other provider 
information. I understand that I am only authorized to access this information if it is required for me 
to conduct my research. This information must not be revealed or discussed with others within or 
outside o f SMHS except to the extent that it is necessary to conduct my research.
I understand that I am required to protect any SMHS patient or operations information from loss, 
misuse, unauthorized access, or unauthorized modification.
I agree to abide by all policies and procedures o f SMHS as it relates to patient confidentiality, medical 
records, and research studies. No unauthorized copies o f data or records will be made or maintained.
I understand that failure to follow all policies regarding the confidentiality o f information is a cause 
for termination o f contract with or revocation o f access to SMHS and may subject me to potential 
civil or criminal liability.
nt /o /xsh ?"
Signature Date
Manager, Clinical Information Services Date
October 2. I99S
fS. RetiHTchSlesearch PackecStFDRECMTD
49
Appendix B
50
SUBJECT DATA FORM
SUBJECT INFORMATION
Subject #____
Gender 1 Male
2 Female
Date o f Birth (m/d/y)
if  female, 
HRT 1 Yes if yes, __ 1 Estrogen
2 No  2 Progesterone
3 Combination
Yes No 
( 1) (2)
Diabetes mellitus __
Family History o f CAD __
Hypertension __
Tobacco use __
ANGIOGRAPHY
Indication; I angina, stable
 2 angina, unstable
 3 atypical chest pain
 4 other____________
Date (m/d/y)
Results
Left Main 
LAD
Left Circumflex 
RCA
% Occlusion PTCA PTCA Date 
( 1)
CABG CABG Date 
( 1)
MYOCARDIAL INFARCTION INFORMATION
Date (m/d/y) /  /  Location  1 Anterior
 2 Lateral
 3 Inferior
 4 Posterior
5 Anterolateral
6 Anteroseptal
7 Infero lateral
8 Inferoposterior
9 Posterolateral
Medications at time o f  MI:
Aspirin
Beta blockers
Calcium channel blockers
Nitrates
“Statins”
Yes No 
( 1) (2)
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SUBJECT DATA FORM MASTER LIST
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No. 
Subject No._ 
Subject No. 
Subject No. 
Subject No. 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No. 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No. 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._ 
Subject No._
Name
Name_
Name_
Name
Name
Name_
Name
Name_
Name
Name
Name
Name_
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name
Name_
Name_
Name
Name
Name
Name
Name
Name
Name_
Name_
Name_
Name
Name
Name
Name_
Name
Name
Name
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D.
D,
D.
D.
D.
D.
D.
D.
D
D.
D.
D.
D.
D
D.
.O.B.
O.B.
.0J3.
.O.B.
.O.B.
O.B.
.OB.
OB.
OB.
OB.
OB.
O.B.
O.B.
O.B.
O.B.
O.B.
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O.B.
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OB
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